Irsenontrine (E2027) is an orally active and selective phosphodiesterase 9 (PDE9) inhibitor. Irsenontrine can be used for the research of neurological diseases[1][2][3].
Molecular Weight:
390.44
Purity:
99.91
CAS Number:
[1429509-82-9]
Formula:
C22H22N4O3
Target:
Phosphodiesterase (PDE)
Application Notes:
Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted